Moderna (MRNA) FY2024 results: revenue $3.2 billion, down 52.7% on the year
Moderna, Inc. (MRNA) reported revenue of $3.2 billion for fiscal 2024, the year ended 31 December 2024, down 52.7% on the year before. Net income was -$3.6 billion, and diluted earnings per share $-9.28. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2025.
Revenue
$3.2 billion
-52.7% on the year
FY2017FY2024
Operating margin
-121.9%
-61.9% a year earlier
FY2017FY2024
Net income
-$3.6 billion
FY2017FY2024
Diluted EPS
-$9.28
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
-3,004
-3,118
4,981
Capital expenditure
1,051
707
400
+48.7%
Free cash flow
-4,055
-3,825
4,581
Free cash flow margin
-125.3%
-55.9%
23.8%
Cash from investing
1,949
4,206
-5,176
-53.7%
Cash from financing
56.0
-1,377
-3,448
Depreciation and amortisation
185
617
348
-70.0%
Share-based compensation
429
305
226
+40.7%
Buybacks
0.0
1,153
3,329
Diluted shares, weighted
384m
382m
416m
+0.5%
Shares outstanding at period end
386m
382m
385m
+1.0%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
10,901
13,854
19,123
-21.3%
Debt
0.0
0.0
0.0
Operating lease liabilities
671
643
92.0
+4.4%
Finance lease liabilities
39.0
575
912
-93.2%
Other liabilities
2,531
3,354
5,731
-24.5%
Total liabilities and equity
14,142
18,426
25,858
-23.2%
Goodwill
52.0
52.0
0.0
0.0%
Intangible assets
40.0
44.0
0.0
-9.1%
Investments
7,592
10,374
15,015
-26.8%
Cash and equivalents
1,927
2,907
3,205
-33.7%
Receivables
358
892
1,385
-59.9%
Inventory
117
202
949
-42.1%
Other assets
4,056
3,955
5,304
+2.6%
Total assets
14,142
18,426
25,858
-23.2%
10-K for the year ended 31 December 2024, filed 21 February 2025: the filing.